Search | European Medicines Agency (EMA)

Napomena o prikazanom jeziku

Ova stranica nije dostupna na odabranom jeziku putem usluge strojnog prevođenja na ovoj internetskoj stranici.
Prikazana je u originalnoj engleskoj verziji.

We improved how this search looks for keywords. We also adjusted search filters. For details, see Website outages and upgrades. You can also download medicine data as published on this website in table format or check our search tips for help.

To fetch data from this website via automated systems, please use our JSON data files

Search results (28130)

PSUSA/00000491/202506 - periodic safety update report single assessment

Active substance(s) in scope of the PSUSA procedure: calcifediol

Procedure number: PSUSA/00000491/202506

Regulatory outcome: Maintenance

Last updated: 5 June 2026

PSUSAHuman

Zarzio

INN or common name:filgrastim

Therapeutic area (MeSH):Hematopoietic Stem Cell Transplantation; Cancer

Marketing authorisation issued: 6 February 2009

Last updated:5 June 2026

Revision: 27

Biosimilar

MedicineHumanAuthorised

Ixchiq

INN or common name:Chikungunya vaccine (live)

Therapeutic area (MeSH):Chikungunya virus

Marketing authorisation issued: 28 June 2024

Last updated:5 June 2026

Revision: 5

Additional monitoring

PRIME: priority medicine

MedicineHumanAuthorised

Ebymect

INN or common name:dapagliflozin; metformin

Therapeutic area (MeSH):Diabetes Mellitus, Type 2

Marketing authorisation issued: 15 November 2015

Last updated:5 June 2026

Revision: 25

MedicineHumanAuthorised

Xigduo

INN or common name:dapagliflozin; metformin

Therapeutic area (MeSH):Diabetes Mellitus, Type 2

Marketing authorisation issued: 16 January 2014

Last updated:5 June 2026

Revision: 27

MedicineHumanAuthorised

Dasselta

INN or common name:desloratadine

Therapeutic area (MeSH):Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria

Marketing authorisation issued: 28 November 2011

Last updated:5 June 2026

Revision: 14

Generic

MedicineHumanAuthorised

HyQvia

INN or common name:human normal immunoglobulin

Therapeutic area (MeSH):Immunologic Deficiency Syndromes; Polyradiculoneuropathy; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Marketing authorisation issued: 16 May 2013

Last updated:5 June 2026

Revision: 26

MedicineHumanAuthorised

CellCept

INN or common name:mycophenolate mofetil

Therapeutic area (MeSH):Graft Rejection

Marketing authorisation issued: 14 February 1996

Last updated:5 June 2026

Revision: 43

MedicineHumanAuthorised

Opsumit

INN or common name:macitentan

Therapeutic area (MeSH):Hypertension, Pulmonary

Marketing authorisation issued: 20 December 2013

Last updated:5 June 2026

Revision: 28

MedicineHumanAuthorised

Tivdak

INN or common name:tisotumab vedotin

Therapeutic area (MeSH):Uterine Cervical Neoplasms

Marketing authorisation issued: 28 March 2025

Last updated:5 June 2026

Revision: 4

Additional monitoring

MedicineHumanAuthorised

Filter by

Search results (28130)